$ALRTF

ALR Technologies SG Ltd.

CIK:0001930419|SEC Filings

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue			$ 25,536
Cost of revenue			(22,096)
Gross Margin			3,440
Operating Expenses
Product development costs	793,327	883,866	1,404,308
Professional fees	617,687	512,555	814,677
Selling, general and administrative expense	1,470,524	2,015,563	2,598,426
Total operating expenses	2,881,538	3,411,984	4,817,411
Loss before other items	(2,881,538)	(3,411,984)	(4,813,971)
Other Items
Interest expense	(19,735,503)	(12,424,430)	(2,521,543)
Foreign exchange loss	(246,207)
Write-off of accounts receivable		(41,100)
Write-off of accounts payable	805,456
Loss on settlement of debt			(139,000)
Total other items	(19,176,254)	(12,465,530)	(2,660,543)
Net Loss	(22,057,792)	(15,877,514)	(7,474,514)
Other Comprehensive Income (Loss)
Exchange difference on translating foreign operations			(6,991)
Comprehensive loss for the year	$ (22,057,792)	$ (15,877,514)	$ (7,481,505)
Weighted Average Number of Shares Outstanding, Diluted	606,994,317	598,924,378	581,016,295
Earnings Per Share, Diluted	$ (0.04)	$ (0.03)	$ (0.01)

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES
Net loss	$ (22,057,792)	$ (15,877,514)	$ (7,474,514)
Share-based compensation included in product development costs, selling, general and administrative expense, professional fees and interest expense	18,270,373	11,531,440	2,867,049
Interest expense on lines of credit	1,834,134	1,731,665	1,644,027
Payment of lines of credit interest	(276,554)	(257,666)	(310,603)
Accrued interest, borrowing costs and interest accretion on loans payable	40,015	307,785	309,706
Non-cash imputed interest expenses	32,509	32,510	34,431
Write-off of accounts receivable		41,100
Unrealized foreign exchange	212,665	(74,458)	35,827
Write-off of accounts payable	(805,456)
Loss on settlement of accounts payable			139,000
Changes in operating assets and liabilities:
Increase in accounts receivable			(41,100)
Decrease (increase) in inventory	20	137	(11,000)
Decrease in prepaid expenses	41,726	16,064	201,645
Increase in accounts payable and accrued liabilities	309,495	477,651	452,450
Increase in interest payable to related parties	327,246	328,186	314,073
Increase in interest payable	203,345	203,344	217,345
Net cash used in operating activities	(1,868,274)	(1,539,756)	(1,621,664)
FINANCING ACTIVITIES
Proceeds from lines of credit	1,825,503	427,839	794,454
Proceeds from loan payable	22,419
Proceeds from promissory notes		1,087,492
Proceeds from exercise of warrants		6,000
Proceeds from sales of ordinary shares			744,655
Net cash provided by financing activities	1,847,922	1,521,331	1,539,109
Effect of foreign exchange on cash			(6,991)
Change in cash	(20,352)	(18,425)	(89,546)
Cash, beginning of year	40,657	59,082	148,628
Cash, end of year	$ 20,305	$ 40,657	$ 59,082

Consolidated Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash	$ 20,305	$ 40,657
Inventory	10,843	10,863
Prepaid expenses	16,226	27,952
Total assets	47,374	79,472
Current liabilities:
Accounts payable and accrued liabilities	1,393,012	1,978,973
Promissory notes payable to related parties	3,091,966	4,179,458
Promissory notes payable	2,163,368	2,163,368
Interest payable to related parties	2,503,511	2,176,265
Interest payable	3,728,759	3,525,414
Lines of credit from related parties	23,196,540	19,857,871
Loan payable to related parties	3,828,847	2,421,842
Total liabilities	39,906,003	36,303,191
Shareholders’ Deficit
Ordinary shares	31,492,506	31,285,637
Additional paid-in capital	86,693,415	68,477,402
Accumulated other comprehensive loss – cumulative translation differences	(844)	(844)
Accumulated deficit	(158,043,706)	(135,985,914)
Total shareholders’ deficit	(39,858,629)	(36,223,719)
Total liabilities and shareholders’ deficit	$ 47,374	$ 79,472